Trenbolone Acetate Formulation

Hazard statements (CLP)

H351, H361fd, H372, H410

Code

Statements

H351

Suspected of causing cancer

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H351 Suspected of causing cancer. H361fd Suspected of damaging fertility. Suspected of damag- ing the unborn child. H372 Causes damage to organs through prolonged or re- peated exposure. H410 Very toxic to aquatic life with long lasting effects.

Prevention

P201 Obtain special instructions before use. P260 Do not breathe dust. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.

Response

P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage.

Hazardous Ingredients

17β-hydroxyestra-4,9,11-trien-3-one 17-acetate

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Carcinogenicity, Category 2 H351: Suspected of causing cancer. Reproductive toxicity, Category 2 H361fd: Suspected of damaging fertility. Suspected of damaging the unborn child. Specific target organ toxicity - repeated H372: Causes damage to organs through pro- exposure, Category 1 longed or repeated exposure. Long-term (chronic) aquatic hazard, Cat- H410: Very toxic to aquatic life with long lasting egory 1 effects.